SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-657305
Filing Date
2016-07-26
Accepted
2016-07-26 07:47:02
Documents
4
Group Members
KEN TAKANASHISNBL USA, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 d228593dsc13da.htm SC 13D/A 79284
2 EX-99.4 d228593dex994.htm EX-99.4 52373
3 EX-99.5 d228593dex995.htm EX-99.5 14834
4 GRAPHIC g228593d0001_228593.jpg GRAPHIC 35121
  Complete submission text file 0001193125-16-657305.txt   196847
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89180 | Film No.: 161783132
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394
Business Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394 81-99-294-2600
Shin Nippon Biomedical Laboratories, Ltd. (Filed by) CIK: 0001657770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13D/A